Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Moderna loses patent fight against Arbutus related to vaccines; Arbutus up 40%

A federal appeals court has upheld a ruling by the U.S. Patent and Trademark Office to not invalidate patents held by $Arbutus Biopharma(ABUS.US)$, dealing a blow to $Moderna(MRNA.US)$.
The court ruled that Moderna had no standing to appeal.
The patents in question cover a novel lipid formulation for nucleic acid delivery. These lipid nanoparticles are essential to protect mRNA therapies as they travel through the body to cells.
As a result, Arbutus may be eligible for royalties from Moderna from sales of its COVID-19 vaccine.
Moderna had argued that the claims in the patents were obvious and upholding them would open the company to patent infringement lawsuits.
Moderna loses patent fight against Arbutus related to vaccines; Arbutus up 40%
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
1
21
+0
13
Translate
Report
73K Views
Comment
Sign in to post a comment

View more comments...

492Followers
80Following
618Visitors
Follow